South Australian company developing Life Whisperer, an AI platform for women's health diagnostics and IVF embryo assessment.
Founded in 2016 and based in South Australia, Australia, Presagen Pty Ltd develops AI-based women's health tools through its Life Whisperer platform, which assesses embryo viability in IVF and reports up to 25% greater accuracy than traditional methods. Its Presagen AI Open Projects lets clinics co-create medical AI products and share royalties. In April 2019 it raised AUD 4.5 million in seed funding led by 3Lines Venture Capital, Jungle Capital Group and the Government of South Australia.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in